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Background Performing ankle brachial index (ABI) to diagnose asymptomatic peripheral arterial disease (APAD) is not feasible for all at risk 
patients.
Methods We performed a post-hoc analysis of NHLBI Limited Access Dataset of Multi-Ethnic study of Atherosclerosis (MESA) (n=6656) free from 
symptomatic PAD (diagnosed PAD or intermittent claudication). Multivariate regression was used to derive HARD2C prediction model for APAD (ABI ≤ 
0.9) and externally validated in National Health and Nutrition Examination Survey (NHANES) (n= 1289) and Cardiovascular Health Study (CHS) (n= 
4143). We also compared the model with current ACC/AHA screening criteria for APAD.
Results Hypertension (9 points), Age (1.5 points per year after 44), African American Race (10 points), Diabetes (9 points), LDL-Cholesterol (1 point 
per 10mg% over 100mg%), Current smoking (20 points) were predictors of APAD. HARD2C score significantly correlated with ABI (Spearman’s rho: 
MESA 0.26, NHANES 0.30, CHS 0.30; (p<0.01) for all) and had prognostic value for future PAD and CVD events, comparable to ABI in MESA cohort.
Conclusion HARD2C is the first externally validated clinical prediction model that not only correlates with abnormal ABI but also independently 
predicts future PAD and CVD events.
External Validation and comparison with ACC/AHA* screening criteria for APAD
*1) Age < 50 yrs with diabetes and 1 additional risk factor (smoking, dyslipidemia, hypertension) 2) Age 50 - 69 yrs and history of smoking or 
diabetes 3) Age 70+ years
Test Characteristics
HARD2C model in 
MESA
ACC/AHA model in 
MESA
HARD2C model in 
NHANES
ACC/AHA model in 
NHANES
HARD2C model 
in CHS
ACC/AHA model 
in CHS
(n= 6656) (n = 1289) (n = 4143)
Sensitivity 80.3 78.7 77.2 81 90.4 91.4
Specificity 66.76 59.1 67.7 51.5 35.5 23.02
NPV 0.99 0.98 0.97 0.96 0.97 0.96
PPV 0.08 0.06 0.19 0.14 0.12 0.11
Positive LR 2.42[2.25-2.60] 1.92[1.79-2.07] 2.41[2.11-2.74] 1.67[1.50-1.86] 1.39[1.25-1.55] 1.18[1.14-1.22]
Negative LR 0.30[0.23-0.38] 0.36[0.28-0.46] 0.34[0.24-0.47] 0.37[0.25-0.54] 0.29[0.22-0.34] 039[0.28-0.54]
Post test Probability of 
positive test
8%[8%-9%] 7%[6%-7%] 19%[17%-21%] 14%[13%-15%] 13%[12%-13%] 11%[11%-11%]
Post test Probability of 
negative test
1%[1%-1%] 1%[1%-2%] 3%[2%-4%] 3%[2%-5%] 3%[2%-4%] 4%[3%-5%]
C-statistic for logistic 
regression
0.73 0.69 0.71 0.66 0.63 0.57
% need to be screened 35% 41% 37.4% 51.5% 66.9% 78.2%
